Effect of cyclosporin A on proteinuria in the course of glomerulopathy associated with WT1 mutations
Open Access
- 17 September 2010
- journal article
- case report
- Published by Springer Nature in European Journal of Pediatrics
- Vol. 170 (3) , 389-391
Abstract
Denys–Drash syndrome (DDS) is characterized by progressive glomerulopathy caused by diffuse mesangial sclerosis (DMS), genitourinary defects, and a higher risk of developing Wilms’ tumor. It is commonly assumed that the DMS is unresponsive to any medications. In this report, we present a patient with Denys–Drash syndrome, in whom the cyclosporine A (CsA) was found to induce total remission. This observation and observations of other authors confirm that in genetic forms of nephrotic syndrome, the proteinuric effect of CsA may be due to a non-immunologic mechanism. We confirm the beneficial effect of CsA treatment in DDS; however, the potential nephrotoxicity of this drug will probably not allow long-term use.Keywords
This publication has 21 references indexed in Scilit:
- Genotype/Phenotype Correlation in Nephrotic Syndrome Caused by WT1 MutationsClinical Journal of the American Society of Nephrology, 2010
- Proteinuria: an enzymatic disease of the podocyte?Kidney International, 2010
- Partial remission with cyclosporine A in a patient with nephrotic syndrome due to NPHS2 mutationPediatric Nephrology, 2009
- Treatment of focal segmental glomerulosclerosis with immunophilin modulation: when did we stop thinking about pathogenesis?Kidney International, 2009
- WT1 gene mutations in three girls with nephrotic syndromeEuropean Journal of Pediatrics, 2007
- Nephrotic Syndrome in the First Year of Life: Two Thirds of Cases Are Caused by Mutations in 4 Genes (NPHS1, NPHS2, WT1, and LAMB2)Pediatrics, 2007
- Positional cloning uncovers mutations in PLCE1 responsible for a nephrotic syndrome variant that may be reversibleNature Genetics, 2006
- WT1 and glomerular diseasesPediatric Nephrology, 2006
- NFAT SignalingCell, 2002
- Long-term effects of cyclosporine A in Alport's syndromeKidney International, 1999